Neuilly-sur-Marne, France

Fabienne Chatreaux

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Marion Roussel. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabienne Chatreaux. Retrieved from https://idiyas.com/inventor/fabienne-chatreaux-pr30eks4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fabienne Chatreaux: Innovator in Antibiotic Compounds

Introduction

Fabienne Chatreaux is a notable inventor based in Neuilly-sur-Marne, France. She has made significant contributions to the field of chemistry, particularly in the development of antibiotic compounds. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Fabienne holds a patent for "Aromatic derivatives substituted by a ribose, their preparation process." This invention involves compounds with antibiotic properties, which are crucial in the fight against bacterial infections. The patent highlights her ability to create novel solutions that can potentially improve health outcomes.

Career Highlights

Throughout her career, Fabienne has worked with Hoechst Marion Roussel, a company known for its commitment to pharmaceutical innovation. Her role in this organization has allowed her to collaborate with other talented professionals and contribute to groundbreaking research in the field.

Collaborations

Fabienne has collaborated with esteemed colleagues such as Laurent Schio and Michel Klich. These partnerships have enriched her work and fostered an environment of shared knowledge and innovation.

Conclusion

Fabienne Chatreaux is a remarkable inventor whose work in antibiotic compounds demonstrates her commitment to improving healthcare. Her contributions through her patent and collaborations highlight the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…